We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

AIDIAN

Aidian, formerly Orion Diagnostica, is a Finnish-based IVD company with almost 50 years of experience in developing a... read more Featured Products: More products

Download Mobile App




Rapid Molecular Diagnostic Test Detects Zika Virus

By LabMedica International staff writers
Posted on 14 Sep 2016
Print article
Image: The GenRead isothermal nucleic acid amplification device (Photo courtesy of Orion Diagnostica).
Image: The GenRead isothermal nucleic acid amplification device (Photo courtesy of Orion Diagnostica).
Zika virus has only recently gained attention due to recent large outbreaks worldwide and an easy to use nucleic acid amplification test (NAAT) could play an important role in the early detection of the infection and patient management.

Diagnosis of Zika virus has so far relied on serological methods, which are often time consuming or nucleic acid amplification tests (NAATs) such as real-time reverse transcription polymerase chain reaction (RT-PCR). RT-PCR requires the use of high precision instruments for thermal cycling reactions and skilled personnel for performing the complex protocol and data interpretation.

Scientists at Orion Diagnostica OY (Espoo, Finland) and a British colleague have developed an alternative NAAT, the reverse transcription strand invasion based amplification (RT-SIBA) assay for the rapid detection of Zika virus. During RT-SIBA reactions, Zika virus ribonucleic acid (RNA) is first reverse transcribed to complementary DNA (cDNA) followed by amplification and detection of cDNA under isothermal reaction conditions. SIBA relies on a recombinase-coated single-stranded invasion oligonucleotide (IO) for the separation of a complementary target duplex. They also compared the performance of RT-SIBA with real-time PCR for the detection of Zika virus. RT-SIBA reaction was performed using the real-time PCR device, Agilent MX3005P (Agilent Technologies, Santa Clara, CA, USA) and parallel reactions performed using a portable fluorescence detection device, Orion GenRead, that is suitable for point-of-care or field applications.

The team found that in RT-SIBA, the time to positive results for 1,000 copies of in vitro transcript RNA template was obtained after an average 17 minutes. Conversely, positive results for 1,000 copies of in vitro transcript RNA template by RT-PCR were obtained after an average 68 minutes. RT-SIBA allows for the simultaneous reverse transcription of Zika virus RNA and amplification of cDNA at the same reaction temperature. This allows for the rapid detection of Zika virus RNA within 30 minutes and was significantly faster than the RT-PCR method. Yellow fever, dengue 1, West Nile, chikungunya virus or any of the 15 different unrelated microorganisms were not detected by the RT-SIBA and RT-PCR Zika assays. This may indicate that both the RT-SIBA and RT-PCR assays are specific for the detection of Zika virus RNA.

The authors concluded that the rapid detection and high analytical sensitivity displayed by RT-SIBA for the detection of Zika virus, as well as tolerance to sample-derived inhibition, demonstrate that the method may be a powerful molecular diagnostic tool for the detection of Zika virus. Since the method can be run on portable and relatively low-cost devices, it may be applied in the rapid response to outbreaks. The study was published on September 1, 2016, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
Orion Diagnostica

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.